Authors: Yang Yanzhen, Zhuang Xianli, Li Shujie, Zhang Ying, Yang Jiagan, Li Lulu DOI: 10.3760/cma.j.cn115989-20210930-00543 Published 2023-01-10 Cite as Chin J Exp Ophthalmol, 2023, 41(1): 22-28. Abstract [Download PDF] [Read Full Text] Objective To study the effect of ranibizumab […]
Tag: Macular degeneration
Inhibitory effect of ZhuJing pill variant formula medicated serum on H2O2-induced epithelial-mesenchymal transition of human RPE cells and its mechanism
Authors: Shao Yan, Zhang Yuanzhong, Yang Ning, Hang Li, Chen Chunming, Li Min, Xu Xinrong DOI: 10.3760/cma.j.cn115989-20210907-00501 Published 2022-11-10 Cite asChin J Exp Ophthalmol, 2022, 40(11): 1013-1022. Abstract [View PDF] [Read Full Text] Objective To study the effect of ZhuJing pill variant […]
Critical guiding role of OCT angiography in long-term treatment and follow-up of neovascular AMD
Authors: Bo Qiyu, Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20220617-00282 Published 2022-07-10 Cite asChin J Exp Ophthalmol, 2022, 40(7): 604-608. Abstract [View PDF] [Read Full Text] The pathogenesis of neovascular age-related macular degeneration (nAMD) is complex and macular neovascularization (MNV), a key pathogenic factor in […]
NLRP3 inflammasome and its role in age-related macular degeneration
Authors: Chen Lu, Xie Ping, Hu Zizhong DOI: 10.3760/cma.j.cn115989-20210922-00527 Published 2022-01-10 Cite as Chin J Exp Ophthalmol, 2022, 40(1): 73-77. Abstract [View PDF] [Read Full Text] Age-related macular degeneration (AMD), the leading cause of central vision loss among people aged 50 years […]
Research progress of purinergic signaling in dry age-related macular degeneration
Authors: Hu Yifan, Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20190717-00316 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 78-82. Abstract [View PDF] [Read Full Text] Age-related macular degeneration (AMD) is one of the major causes of visual loss in people over 65 years […]